A HIGHLY experimental treatment has dramatically shrunk deadly skin cancers in several patients, all by knocking out natural immune cells to make way for an army of tumour-attacking cells.
Only 13 people have had the treatment so far and it hasn’t worked for all of them. But it is already attracting attention as a potential approach against infectious diseases such as AIDS as well as cancer.
The treatment takes advantage of a subset of T cells, a major part of our immune system, which can recognise proteins that are rife in tumour cells. These T cells provide a natural protection…
